Behind the Headline: Why a Controversial COVID-19 Mortality Study Was Retracted

A widely discussed study about excess deaths during the COVID-19 pandemic has now been retracted by BMJ Public Health, bringing renewed attention to an important question: How can a study containing real data still lead readers toward conclusions the evidence does not establish?

The paper, published in 2024, examined mortality trends across 47 Western countries between 2020 and 2022. It reported more than 3 million excess deaths during that period. Those numbers were real measurements of population-level mortality, but the study did not establish what caused those deaths.

That distinction became central to the controversy.

Following concerns about the paper’s quality and messaging, BMJ Public Health issued an expression of concern in 2024. The journal warned readers that the analysis did not establish a causal relationship between COVID-19 vaccination, containment measures and excess mortality.

In August 2026, the journal formally retracted the article, stating that its discussion of possible causes of excess mortality was imbalanced, lacked rigor and contained misinformation. The journal also said the limited nature of the original analysis had not been adequately described.

What the Original Study Actually Found

The underlying question was legitimate.

Researchers used publicly available all-cause mortality information to compare the number of deaths observed during 2020–2022 with the number expected based on previous mortality patterns.

Their analysis estimated approximately 3.1 million excess deaths across 47 countries over those three years. The paper estimated about 1.03 million excess deaths in 2020, 1.26 million in 2021 and 808,000 in 2022.

Excess mortality is an established public-health measure. It can capture deaths directly caused by a disease as well as deaths indirectly associated with a health crisis.

For example, during a major pandemic, excess deaths could potentially reflect:

  • Direct deaths from infection
  • Delayed medical treatment
  • Disrupted cancer screening
  • Changes in cardiovascular care
  • Healthcare-system pressure
  • Population aging
  • Changes in recording or reporting
  • Other social and medical factors

The important point is that an excess-death calculation identifies a mortality pattern, not its cause.

That was where the study’s interpretation became controversial.

The Problem With Turning a Trend Into a Cause

Imagine that deaths increase during the same period that a new medical treatment is introduced.

It is tempting to conclude that the treatment caused the increase.

But that conclusion requires much more information.

Researchers would need to know who received the treatment, who did not, when they received it, their medical histories, their age and other risk factors, and what they actually died from.

The retracted paper did not provide that individual-level evidence.

Instead, it compared population-level mortality trends across countries and discussed several possible explanations. The journal’s expression of concern specifically warned that the study had been misreported as demonstrating a direct relationship between COVID-19 vaccination and mortality when it had not.

This is a classic epidemiological problem known as an ecological fallacy: relationships observed at the population level cannot automatically be assumed to apply to individual people.

Why the Timing Was Especially Misleading

Another issue was timing.

COVID-19 infections, public-health restrictions and vaccination campaigns occurred during overlapping periods, but they did not happen simultaneously or in exactly the same way everywhere.

Different countries experienced different infection waves. Vaccination programs were introduced at different times and initially prioritized different populations. Restrictions also varied considerably.

That makes a simple comparison of “before” and “after” periods difficult to interpret.

The journal’s review noted that comparing countries and time points without adequately accounting for these differences could produce misleading conclusions.

In other words, when two things happen during the same period, timing alone cannot establish causation.

Retraction Does Not Mean Every Number Was Fabricated

This is an important distinction that can easily get lost online.

The retraction does not mean that every mortality record used in the paper was invented or that excess deaths did not occur.

The mortality phenomenon itself is well documented.

What failed was the paper’s treatment of the possible causes of those deaths.

The journal ultimately concluded that the discussion was sufficiently problematic that the article should be withdrawn rather than simply corrected.

That distinction matters because scientific research often contains several layers:

Data → Analysis → Interpretation → Conclusion

A dataset can be legitimate while an interpretation drawn from it is flawed.

Why Excess Mortality Is Still Worth Studying

The retraction should not discourage investigation into excess deaths.

Quite the opposite.

Understanding why mortality remained elevated during and after the acute phase of the pandemic remains an important public-health question.

Researchers need to examine multiple potential contributors rather than assume a single explanation.

COVID-19 itself caused substantial illness and death, while infections can also contribute to cardiovascular, respiratory and other complications. At the same time, healthcare disruptions during the pandemic affected routine medical care in many countries.

Cancer diagnoses, elective procedures and chronic-disease management were disrupted in numerous healthcare systems.

There were also major demographic and social changes during the period.

Separating these effects requires detailed data—not simply a comparison of national mortality curves.

What This Teaches Us About Health Headlines

The story offers a useful lesson for anyone who reads health news online.

A dramatic number can be completely genuine while the headline attached to it goes too far.

When you encounter a claim involving vaccines, medications, supplements or disease risk, ask four simple questions:

1. What Did Researchers Actually Measure?

Was it blood pressure, mortality, infection, symptoms or something else?

Understanding the measurement often reveals what the study can—and cannot—tell us.

2. Was the Study Designed to Establish Causation?

Randomized trials and carefully designed longitudinal studies can provide much stronger evidence about causality than broad population comparisons.

3. Were Alternative Explanations Considered?

Strong research does not begin with one favored explanation and work backward. It tests competing possibilities.

4. What Happened After Peer Review?

Scientific understanding does not end when a paper is published. Other researchers scrutinize methods, reproduce findings and challenge interpretations.

In this case, concerns led to an expression of concern, further investigation and ultimately retraction.

The Bigger Lesson for Public Health

Scientific retractions can be uncomfortable, particularly when research has already become part of a heated public debate.

But correcting the scientific record is a feature—not a failure—of responsible research.

The original paper raised a legitimate question about persistent excess mortality. Its mistake was going beyond what its data could demonstrate.

That is a lesson worth remembering as health information becomes increasingly fast-moving and emotionally charged.

Good science does not simply ask whether a number is real. It asks what that number actually means—and whether the evidence is strong enough to support the conclusion being presented.

Photo by Maksim Goncharenok: https://www.pexels.com/photo/close-up-shot-of-vials-5995163/

Leave a Reply

Your email address will not be published. Required fields are marked *